Literature DB >> 12488540

Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory.

Andrew C Charles1, Natalya Mostovskaya, Kathleen Asas, Christopher J Evans, Megan L Dankovich, Tim G Hales.   

Abstract

GH3 cells show spontaneous activity characterized by bursts of action potentials and oscillations in [Ca 2+]i. This activity is modulated by the activation of exogenously expressed opioid receptors. In GH3 cells expressing only micro receptors (GH3MOR cells), the micro receptor-specific ligand [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) inhibited spontaneous Ca 2+ signaling by the inhibition of voltage-gated Ca 2+ channels, activation of inward-rectifying K+ channels, and inhibition of adenylyl cyclase. In contrast, in cells expressing both micro and delta receptors (GH3MORDOR cells), DAMGO had an excitatory effect on Ca 2+ signaling that was mediated by phospholipase C and release of Ca 2+ from intracellular stores. The excitatory effect of DAMGO was also inhibited by pretreatment with pertussis toxin. Despite the excitatory effect on Ca 2+ signaling, DAMGO inhibited Ca 2+ channels and activated inward-rectifying K+ channels in GH3MORDOR cells, although to a lesser extent than in GH3MOR cells. Long-term treatment with the delta receptor-specific ligand [D-Pen2,D-Pen5]-enkephalin reduced the excitatory effect of DAMGO in the majority of GH3MORDOR cells and restored the inhibitory response to DAMGO in some cells. The inhibitory effect of somatostatin on Ca 2+ signaling was not different in GH3MORDOR versus GH3MOR cells. These results indicate that interaction between micro- and delta-opioid receptors causes a change in the functional response to micro ligands, possibly by the formation of a micro/delta heterodimer with distinct functional properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12488540     DOI: 10.1124/mol.63.1.89

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  28 in total

Review 1.  Roles of G-protein-coupled receptor dimerization.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

2.  The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization.

Authors:  Anke Teichmann; Claudia Rutz; Annika Kreuchwig; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

3.  The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity.

Authors:  Katharina Schulz; Claudia Rutz; Carolin Westendorf; Ingrid Ridelis; Susanne Vogelbein; Jens Furkert; Antje Schmidt; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

Review 4.  Targeting opioid receptor heterodimers: strategies for screening and drug development.

Authors:  Achla Gupta; Fabien M Décaillot; Lakshmi A Devi
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

5.  Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers.

Authors:  Raphael Rozenfeld; Lakshmi A Devi
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

Review 6.  Membrane functional organisation and dynamic of mu-opioid receptors.

Authors:  André Lopez; Laurence Salomé
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

7.  Direct bidirectional μ-opioid control of midbrain dopamine neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Wakako Fujita; Howard L Fields
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

Review 8.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 9.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

Review 10.  Modulation of pain transmission by G-protein-coupled receptors.

Authors:  Hui-Lin Pan; Zi-Zhen Wu; Hong-Yi Zhou; Shao-Rui Chen; Hong-Mei Zhang; De-Pei Li
Journal:  Pharmacol Ther       Date:  2007-09-22       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.